| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,294 |
3,041 |
$185K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,743 |
2,002 |
$92K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
645 |
616 |
$61K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
508 |
508 |
$42K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
494 |
493 |
$41K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,831 |
2,818 |
$26K |
| 90461 |
|
728 |
727 |
$25K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
216 |
213 |
$17K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
182 |
182 |
$17K |
| 99050 |
|
966 |
940 |
$16K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,467 |
1,467 |
$15K |
| 96127 |
|
938 |
938 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
145 |
142 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
75 |
74 |
$6K |
| 92551 |
|
472 |
471 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
342 |
341 |
$3K |
| 36416 |
|
192 |
192 |
$2K |
| 99173 |
|
97 |
96 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
104 |
104 |
$1K |
| 99174 |
|
38 |
38 |
$864.88 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
60 |
60 |
$725.40 |
| 83655 |
|
58 |
58 |
$724.42 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
22 |
20 |
$680.90 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
17 |
17 |
$398.99 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
17 |
17 |
$186.15 |
| 85018 |
|
58 |
58 |
$123.04 |